Husarova Tereza, MacCuaig William M, Dennahy Isabel S, Sanderson Emma J, Edil Barish H, Jain Ajay, Bonds Morgan M, McNally Molly W, Menclova Katerina, Pudil Jiri, Zaruba Pavel, Pohnan Radek, Henson Christina E, Grizzle William E, McNally Lacey R
Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA.
Department of Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic.
Cancers (Basel). 2023 Jul 20;15(14):3694. doi: 10.3390/cancers15143694.
Hepatopancreatobiliary surgery belongs to one of the most complex fields of general surgery. An intricate and vital anatomy is accompanied by difficult distinctions of tumors from fibrosis and inflammation; the identification of precise tumor margins; or small, even disappearing, lesions on currently available imaging. The routine implementation of ultrasound use shifted the possibilities in the operating room, yet more precision is necessary to achieve negative resection margins. Modalities utilizing fluorescent-compatible dyes have proven their role in hepatopancreatobiliary surgery, although this is not yet a routine practice, as there are many limitations. Modalities, such as photoacoustic imaging or 3D holograms, are emerging but are mostly limited to preclinical settings. There is a need to identify and develop an ideal contrast agent capable of differentiating between malignant and benign tissue and to report on the prognostic benefits of implemented intraoperative imaging in order to navigate clinical translation. This review focuses on existing and developing imaging modalities for intraoperative use, tailored to the needs of hepatopancreatobiliary cancers. We will also cover the application of these imaging techniques to theranostics to achieve combined diagnostic and therapeutic potential.
肝胰胆外科属于普通外科中最复杂的领域之一。其解剖结构复杂且至关重要,同时存在肿瘤与纤维化及炎症难以区分、精确肿瘤边界的识别困难,以及在当前可用影像上存在小的甚至正在消失的病变等问题。超声的常规应用改变了手术室中的可能性,但要实现切缘阴性仍需要更高的精准度。利用荧光兼容染料的技术已在肝胰胆外科中证明了其作用,不过由于存在诸多限制,这尚未成为常规做法。光声成像或3D全息图等技术正在兴起,但大多局限于临床前研究。需要识别和开发一种能够区分恶性和良性组织的理想造影剂,并报告术中成像在临床转化中的预后益处。本综述聚焦于为满足肝胰胆癌需求而现有的和正在发展的术中成像技术。我们还将涵盖这些成像技术在诊疗一体化中的应用,以实现联合诊断和治疗潜力。